Skip to main content
. 2018 Jan 29;8:1760. doi: 10.1038/s41598-018-19784-2

Figure 1.

Figure 1

Illustration of CRISPR/Cas9 genome editing approach of hybridoma cells for site-specific modification of antibodies. Hybridoma cells were modified by co-transfection with plasmid expressing sgRNA and Cas9, and linearized HDR repair plasmid. After 48 hrs, GFP-positive cells were isolated using fluorescence-activated cell sorting (FACS) into 96 well plates and cultured. Clones were analyzed for incorporation if inserted tag by gel and sequence analysis.